Welcome!

News Feed Item

Immunotec Announces 2013 Fourth Quarter and Full Year Financial Results

Best results since going public in 2007 (Revenues achieving a record $54.8M and Net Profit reaching $1.4M)

VAUDREUIL-DORION, QUEBEC -- (Marketwired) -- 02/13/14 -- Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the wellness industry (the "Company") today released its fourth quarter and full year results for the period ended 31 October 2013.

The Company, led by its consultants and employees, made significant progress as shown in its performance against key metrics" said Mr. Charles L. Orr, Immunotec's Chief Executive Officer. "We are grateful for how all our stakeholders are collaborating to support Immunotec's vision to become the company of choice for nutrition and lifestyle improvement".

"The 2013 Financial Results are the strongest since the Company became public in 2007", said Mr. Patrick Montpetit, Immunotec's Chief Financial Officer. "We are pleased with the trend of financial results over the last eight quarters and the potential for the quarters ahead".

2013 and Subsequent Year-End Highlights:


--  Total revenues reached $54.8M, an increase of 11.3% as compared to the
    previous year. 
    
--  Network sales reached $49.6M, an increase of 12.2% as compared to the
    previous year. 
    
--  Selected expenses(1), defined as administrative, marketing and selling,
    and quality and development expenses amounted to $11.9M and measured
    favourably as a percentage of total revenues by improving to 21.7% as
    compared to 24.0% in the previous year. 
    
--  Adjusted EBITDA(1), amounted to $2.9M or 5.2% of total revenues,
    compared to $1.9M or 3.8% of total revenues in the previous year. 
    
--  Net profit of $1.4M, compared to $0.1M in the previous year. 
    
--  Total basic and fully diluted profit per common share was $0.02. 
    
--  The Company repurchased a total of 732,000 shares under the Normal
    Course Issuer Bid ("NCIB") program.

For the year ended 31 October 2013, Immunotec recorded Network sales of $49.6M as compared to $44.2M for the previous year, an increase of 12.2% or $5.4M. This increase was driven by a $4.8M gain over the previous year from the Mexican operations. Other revenue, which includes revenues of products sold to licensees, freight and shipping and educational material purchased by our network of independent consultants, was stable at $5.1M compared to $5.0M in the previous year.

Sales incentives paid to our Network is the Company's most significant expense and consists of commissions, performance bonuses and other promotional incentives provided to qualifying consultants. During the year ended 31 October 2013, the Company incurred $25.8M in Sales incentives paid to our Network for an average of 51.9% of total Network sales compared to 51.1% of total Network sales in the previous year.

Selected expenses(1) in year ended 31 October 2013 amounted to $11.9M as compared to $11.8M for the previous year. As a result of the growth in revenues in 2013 being achieved without a commensurate growth in these expenses, their percentage of total revenues improved to 21.7% as compared to 24.0% in the previous year.

For the year ended 31 October 2013, adjusted EBITDA(1) was $2.9M or 5.2% of revenues, versus $1.9M or 3.8% for the previous year. Adjusted EBITDA has improved 53.0% over the previous year while revenue increased 11.3% reflecting a disciplined approach to expense management.

Net profit for the year ended 31 October 2013 totalled $1.4M, as compared to net profit of $0.1M for the previous year. This year-over-year improvement is primarily the result of revenue growth in Mexico. Total basic and fully diluted profit per common share for the year ended 31 October 2013 was $0.02, compared to $0.00 in the previous year.

During the year, under the Normal Course Issuer Bid (NCIB) program, the Company repurchased and cancelled 732,000 common shares for cash consideration of $0.2M, whereas repurchases made in the corresponding period in the previous year were not significant.

Subsequent to the year ended 31 October 2013, the Company amended the terms and conditions of its existing credit facilities with the lender. An additional tranche of up to approximately $0.25M was added to the existing Committed Reducing Term Facility, bearing interest at 3.63%, and maturing in September 2016. This amount was received in January 2014. A new Committed Reducing Term Facility in the amount of $0.5M, bearing interest at 4.34% and maturing in February 2017 was added. Certain additional collateralization was included in the agreement, including cross-guarantees from Group companies. The entire $0.5M amount was drawn in February 2014.

Pursuant to the Immunotec Stock Option Plan, on 17 February 2014, a director will be granted 25,000 options to acquire up to an aggregate of 25,000 common shares (the "Shares"). The exercise price of such options will be established at the closing trading price on that day. These options will vest over a three-year period, with one-third (1/3) which will vest on each of the first, second and third anniversaries of the date of the grant. Each option is exercisable, once vested, for a period of five years from the date of the grant.

Financial Results for the Fourth Quarter of 2013

In the three-month period ended 31 October 2013, total revenue reached $15.5M, an increase of 13.1% as compared to the same period in the previous year when total revenues were $13.7M. Of this amount, Network sales comprised $14.2M or 91.6% of total sales, as compared to 89.8% in the same period in the previous year when Network sales were $12.3M. The fourth quarter increase is due primarily to sales growth in Mexico and the Western United States.

Selected expenses(1) as a percentage of total revenues were 16.1% in the three- month period ended 31 October 2013, as compared to 21.2% of total revenues for the same quarter in the previous year. This improvement in the fourth quarter is due primarily to improved administrative costs and the recognition of research and development tax credits in Canada.

The net profit in the three-month period ended 31 October 2013 was $0.4M, compared to a loss of $0.1M in the same period in the previous year.

About Immunotec Inc.

Immunotec Inc. is dedicated to making a positive difference in people's lifestyle every day by offering research-driven nutritional products through its network of Independent Consultants worldwide. Immunotec's strength comes from its culture that emphasizes teamwork and entrepreneurial leadership by employees, consultants and research collaborators.

Headquartered with manufacturing facilities near Montreal, Canada, Immunotec Consultants generate nearly $55.0 Million in annual revenues. Please visit us at www.immunotec.com for additional information.

The Company files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at www.sedar.com and on the Company's website at www.immunotec.com. The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at www.sedar.com. Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.

Selected Financial Information

The following tables summarize selected financial information from the Consolidated Statements of Income and the Consolidated Statements of Financial Position regarding the Company's results of operations and financial position.


                       Selected Financial Information                       
                                                                            
                                                                            
For the years ended 31 October                                              
('000s of C$, except for share and per share                                
 data)                                                  2013           2012 
----------------------------------------------------------------------------
                                                                            
Revenues                                              54,771         49,206 
Cost of goods sold                                     9,989          8,858 
Sales incentives - Network                            25,786         22,616 
Other variable costs                                   4,505          4,260 
----------------------------------------------------------------------------
Margin before expenses                                14,491         13,472 
Expenses                                              13,456         13,261 
----------------------------------------------------------------------------
Operating income                                       1,035            211 
Net finance (income) expenses                            (64)            85 
Income taxes (recovery)                                 (278)             1 
----------------------------------------------------------------------------
Net profit                                             1,377            125 
----------------------------------------------------------------------------
Total comprehensive income (loss)                      1,293             (2)
                                                                            
Net profit per share:                                                       
Basic and diluted                                       0.02           0.00 
Weighted average common shares oustanding:                                  
Basic and diluted                                 69,600,040     69,985,287 
----------------------------------------------------------------------------
                                                                            
                                                                            
As at                                             31 October     31 October 
(000's of C$)                                           2013           2012 
----------------------------------------------------------------------------
Cash (net of bank indebtedness)                        4,706          3,774 
Total assets                                          23,495         19,932 
Long- term liabilities (including current                                   
 portions)                                             2,021          2,081 
Equity                                                13,071         11,972 
----------------------------------------------------------------------------
                                                                            
                                                                            
                                                                            
                     Geographic distribution of revenues                    
                                                                            
For the year ended 31 October                                               
('000s of C$)                                           2013           2012 
----------------------------------------------------------------------------
                                                                            
Mexico                                                24,064         18,268 
Canada                                                13,897         15,055 
United States                                         14,057         13,444 
Other countries                                        2,753          2,439 
----------------------------------------------------------------------------
                                                      54,771         49,206 
----------------------------------------------------------------------------
                                                                            
                                                                            
                                                                            
           Selected expenses as a percentage (%) of total revenue           
                                                                            
For the year ended 31 October                                               
('000s of C$)                                2013       %      2012       % 
----------------------------------------------------------------------------
                                                                            
Revenues                                   54,771   100.0%   49,206   100.0%
Selected expenses                                                           
Administrative                              6,072    11.1%    5,964    12.1%
Marketing and selling                       5,227     9.5%    4,974    10.1%
Quality and development costs                 603     1.1%      891     1.8%
----------------------------------------------------------------------------
                                           11,902    21.7%   11,829    24.0%
----------------------------------------------------------------------------
                                                                            
                                                                            
                                                                            
                       Calculation of adjusted EBITDA                       
                                                                            
For the year ended 31 October                                               
('000s of C$)                                                 2013     2012 
----------------------------------------------------------------------------
                                                                            
Net profit                                                   1,377      125 
                                                                            
Add (deduct):                                                               
  Depreciation and amortization                                814      946 
  Net finance (income) expenses                                (64)      85 
  Administrative assessments from a foreign jurisdiction       282      233 
  Other expenses                                               740      487 
  Income tax (recovery) expense                               (278)       1 
----------------------------------------------------------------------------
Adjusted EBITDA                                              2,871    1,877 
----------------------------------------------------------------------------
                                                                            
Percentage of revenues                                         5.2%     3.8%
----------------------------------------------------------------------------

(1) Adjusted EBITDA and Selected Expenses are a non-GAAP measures providing additional information on the commercial performance of regular operations. Adjusted EBITDA corresponds to EBITDA as defined Earnings before Interest Taxes Depreciation and Amortization less elements that management considers outside of the normal activities of the Company. Selected Expenses correspond to general administration charges and fixed overhead charges in the normal activities of the Company. For more information please refer to the non-GAAP measures section of the most recent Management Discussion and Analysis filed on www.sedar.com.

Contacts:
Patrick Montpetit CPA, CA, CF
Vice-President and Chief Financial Officer,
Immunotec Inc.
(450) 510-4527

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
How will your company move to the cloud while ensuring a solid security posture? Organizations from small to large are increasingly adopting cloud solutions to deliver essential business services at a much lower cost. According to cyber security experts, the frequency and severity of cyber-attacks are on the rise, causing alarm to businesses and customers across a variety of industries. To defend against exploits like these, a company must adopt a comprehensive security defense strategy that is ...
Companies can harness IoT and predictive analytics to sustain business continuity; predict and manage site performance during emergencies; minimize expensive reactive maintenance; and forecast equipment and maintenance budgets and expenditures. Providing cost-effective, uninterrupted service is challenging, particularly for organizations with geographically dispersed operations.
SYS-CON Events announced today that BMC Software has been named "Siver Sponsor" of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2015 at the Javits Center in New York, New York. BMC is a global leader in innovative software solutions that help businesses transform into digital enterprises for the ultimate competitive advantage. BMC Digital Enterprise Management is a set of innovative IT solutions designed to make digital business fast, seamless, and optimized from mainframe to mo...
SoftLayer operates a global cloud infrastructure platform built for Internet scale. With a global footprint of data centers and network points of presence, SoftLayer provides infrastructure as a service to leading-edge customers ranging from Web startups to global enterprises. SoftLayer's modular architecture, full-featured API, and sophisticated automation provide unparalleled performance and control. Its flexible unified platform seamlessly spans physical and virtual devices linked via a world...
The IoT is changing the way enterprises conduct business. In his session at @ThingsExpo, Eric Hoffman, Vice President at EastBanc Technologies, discuss how businesses can gain an edge over competitors by empowering consumers to take control through IoT. We'll cite examples such as a Washington, D.C.-based sports club that leveraged IoT and the cloud to develop a comprehensive booking system. He'll also highlight how IoT can revitalize and restore outdated business models, making them profitable...
The cloud market growth today is largely in public clouds. While there is a lot of spend in IT departments in virtualization, these aren’t yet translating into a true “cloud” experience within the enterprise. What is stopping the growth of the “private cloud” market? In his general session at 18th Cloud Expo, Nara Rajagopalan, CEO of Accelerite, will explore the challenges in deploying, managing, and getting adoption for a private cloud within an enterprise. What are the key differences betwee...
IoT generates lots of temporal data. But how do you unlock its value? How do you coordinate the diverse moving parts that must come together when developing your IoT product? What are the key challenges addressed by Data as a Service? How does cloud computing underlie and connect the notions of Digital and DevOps What is the impact of the API economy? What is the business imperative for Cognitive Computing? Get all these questions and hundreds more like them answered at the 18th Cloud Expo...
SYS-CON Events announced today the Docker Meets Kubernetes – Intro into the Kubernetes World, being held June 9, 2016, in conjunction with 18th Cloud Expo | @ThingsExpo, at the Javits Center in New York, NY. Register for 'Docker Meets Kubernetes Workshop' Here! This workshop led by Sebastian Scheele, co-founder of Loodse, introduces participants to Kubernetes (container orchestration). Through a combination of instructor-led presentations, demonstrations, and hands-on labs, participants learn ...
As organizations shift towards IT-as-a-service models, the need for managing and protecting data residing across physical, virtual, and now cloud environments grows with it. Commvault can ensure protection, access and E-Discovery of your data – whether in a private cloud, a Service Provider delivered public cloud, or a hybrid cloud environment – across the heterogeneous enterprise. In his general session at 18th Cloud Expo, Randy De Meno, Chief Technologist - Windows Products and Microsoft Part...
In his session at 18th Cloud Expo, Andrew Cole, Director of Solutions Engineering at Peak 10, will discuss how the newest technology advances are reducing the cost and complexity of traditional business continuity and disaster recovery solutions. Attendees will: Learn why having a full disaster recovery strategy is more important now than ever before Explore the key drivers of a successful disaster recovery solution Achieve measurable operational and business value from a disaster recovery ...
SYS-CON Events announced today that EastBanc Technologies will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. EastBanc Technologies has been working at the frontier of technology since 1999. Today, the firm provides full-lifecycle software development delivering flexible technology solutions that seamlessly integrate with existing systems – whether on premise or cloud. EastBanc Technologies partners with p...
SYS-CON Events announced today that Hanu Software will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Leveraging best-in-class people, processes, and technologies, Hanu provides high-quality, high-value software development and business process outsourcing services to independent software vendors (ISVs) and enterprises.
SYS-CON Events announced today Object Management Group® has been named “Media Sponsor” of SYS-CON's 18th International Cloud Expo, which will take place on June 7–9, 2016, at the Javits Center in New York City, NY, and the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
In his session at 18th Cloud Expo, Bruce Swann, Senior Product Marketing Manager at Adobe, will discuss how the Adobe Marketing Cloud can help marketers embrace opportunities for personalized, relevant and real-time customer engagement across offline (direct mail, point of sale, call center) and digital (email, website, SMS, mobile apps, social networks, connected objects). Bruce Swann has more than 15 years of experience working with digital marketing disciplines like web analytics, social med...
SYS-CON Events announced today that Commvault, a global leader in enterprise data protection and information management, has been named “Bronze Sponsor” of SYS-CON's 18th International Cloud Expo, which will take place on June 7–9, 2016, at the Javits Center in New York City, NY, and the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. Commvault is a leading provider of data protection and information management...